Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial
Clinical Infectious Diseases (2022) - Comments
pubmed: 35234868  doi: 10.1093/cid/ciac169  issn: 1058-4838  issn: 1537-6591 

Benjamin Speich, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, Barbara Hasse, Dominique L Braun, Macé M Schuurmans, Thomas F Müller, Michael Tamm, Annette Audigé, Nicolas J Mueller, Andri Rauch, Huldrych F Günthard, Michael T Koller, Alexandra Trkola, Matthias Briel, Katharina Kusejko, Heiner C Bucher